与INSURE程序(插管-表面活性剂-拔管)失败相关的危险因素,用于给早产儿表面活性剂< 1500 g

D. Morales-Barquet , A.J. Ortega-Vargas , J. Lara-Canul , G. Arreola-Ramírez , L.A. Fernández-Carrocera
{"title":"与INSURE程序(插管-表面活性剂-拔管)失败相关的危险因素,用于给早产儿表面活性剂< 1500 g","authors":"D. Morales-Barquet ,&nbsp;A.J. Ortega-Vargas ,&nbsp;J. Lara-Canul ,&nbsp;G. Arreola-Ramírez ,&nbsp;L.A. Fernández-Carrocera","doi":"10.1016/j.rprh.2018.01.004","DOIUrl":null,"url":null,"abstract":"<div><p>Neonatal Respiratory Distress Syndrome (RDS) is caused by pulmonary surfactant deficiency. The initial respiratory support is currently nasal continuous positive airway pressure (Nasal CPAP), and is associated with the decreased need of intubation and mechanical ventilation. The INSURE procedure (Intubation-Surfactant-Extubation) for surfactant administration, is associated with a lower need of supplementary oxygen at 28 days of life. The aim of this study is to identify the frequency of failure of the INSURE procedure, defined as the need for re-intubation in the following 72<!--> <!-->hours, the risk factors and neonatal outcomes associated with the failure of this procedure.</p></div><div><h3>Material and methods</h3><p>An observational, retrospective, analytical study was conducted that included all newborns with birth weight &lt;1500<!--> <!-->g, and in whom surfactant was administered using the INSURE procedure, between 1 March 2011 and 31 March 2014.</p></div><div><h3>Results</h3><p>A total of 183 cases were managed using the INSURE procedure, finding that 38.8% of the failures were due to the technique, with the main cause being apnoea. Risk factors found were, a lower gestational age, lower birth weight, and a higher grade of respiratory distress prior to using INSURE. Within the neonatal outcomes, a significant association was found with the increased use of mechanical ventilation, days of supplemental oxygen, and bronchopulmonary disease, and mortality in the failure group.</p></div><div><h3>Conclusion</h3><p>An increased risk of failure in the INSURE procedure was associated with lower gestational age and lower birth weight.</p></div>","PeriodicalId":32275,"journal":{"name":"Perinatologia y Reproduccion Humana","volume":"31 3","pages":"Pages 124-130"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rprh.2018.01.004","citationCount":"1","resultStr":"{\"title\":\"Factores de riesgo asociados a la falla en el procedimiento INSURE (Intubación - Surfactante - Extubación) para la administración de surfactante en recién nacidos prematuros < 1,500 g\",\"authors\":\"D. Morales-Barquet ,&nbsp;A.J. Ortega-Vargas ,&nbsp;J. Lara-Canul ,&nbsp;G. Arreola-Ramírez ,&nbsp;L.A. Fernández-Carrocera\",\"doi\":\"10.1016/j.rprh.2018.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Neonatal Respiratory Distress Syndrome (RDS) is caused by pulmonary surfactant deficiency. The initial respiratory support is currently nasal continuous positive airway pressure (Nasal CPAP), and is associated with the decreased need of intubation and mechanical ventilation. The INSURE procedure (Intubation-Surfactant-Extubation) for surfactant administration, is associated with a lower need of supplementary oxygen at 28 days of life. The aim of this study is to identify the frequency of failure of the INSURE procedure, defined as the need for re-intubation in the following 72<!--> <!-->hours, the risk factors and neonatal outcomes associated with the failure of this procedure.</p></div><div><h3>Material and methods</h3><p>An observational, retrospective, analytical study was conducted that included all newborns with birth weight &lt;1500<!--> <!-->g, and in whom surfactant was administered using the INSURE procedure, between 1 March 2011 and 31 March 2014.</p></div><div><h3>Results</h3><p>A total of 183 cases were managed using the INSURE procedure, finding that 38.8% of the failures were due to the technique, with the main cause being apnoea. Risk factors found were, a lower gestational age, lower birth weight, and a higher grade of respiratory distress prior to using INSURE. Within the neonatal outcomes, a significant association was found with the increased use of mechanical ventilation, days of supplemental oxygen, and bronchopulmonary disease, and mortality in the failure group.</p></div><div><h3>Conclusion</h3><p>An increased risk of failure in the INSURE procedure was associated with lower gestational age and lower birth weight.</p></div>\",\"PeriodicalId\":32275,\"journal\":{\"name\":\"Perinatologia y Reproduccion Humana\",\"volume\":\"31 3\",\"pages\":\"Pages 124-130\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.rprh.2018.01.004\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Perinatologia y Reproduccion Humana\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0187533718300049\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perinatologia y Reproduccion Humana","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0187533718300049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

新生儿呼吸窘迫综合征(RDS)是由肺表面活性物质缺乏引起的。最初的呼吸支持目前是鼻腔持续气道正压通气(nasal CPAP),并与插管和机械通气的需求减少有关。表面活性剂给药的INSURE程序(插管-表面活性剂-拔管)与28天生命中较低的补充氧需求有关。本研究的目的是确定INSURE手术失败的频率,定义为在接下来的72小时内需要再次插管,风险因素和与该手术失败相关的新生儿结局。材料与方法在2011年3月1日至2014年3月31日期间进行了一项观察性、回顾性和分析性研究,纳入了所有出生体重为1500 g的新生儿,并使用INSURE程序给予表面活性剂。结果使用INSURE程序管理183例患者,38.8%的失败是由于该技术导致的,主要原因是呼吸暂停。发现的危险因素是,在使用INSURE之前,较低的胎龄、较低的出生体重和较高程度的呼吸窘迫。在新生儿结局中,发现衰竭组中机械通气、补充氧天数、支气管肺疾病和死亡率的增加与显著相关。结论:低胎龄和低出生体重与保险手术失败风险增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Factores de riesgo asociados a la falla en el procedimiento INSURE (Intubación - Surfactante - Extubación) para la administración de surfactante en recién nacidos prematuros < 1,500 g

Neonatal Respiratory Distress Syndrome (RDS) is caused by pulmonary surfactant deficiency. The initial respiratory support is currently nasal continuous positive airway pressure (Nasal CPAP), and is associated with the decreased need of intubation and mechanical ventilation. The INSURE procedure (Intubation-Surfactant-Extubation) for surfactant administration, is associated with a lower need of supplementary oxygen at 28 days of life. The aim of this study is to identify the frequency of failure of the INSURE procedure, defined as the need for re-intubation in the following 72 hours, the risk factors and neonatal outcomes associated with the failure of this procedure.

Material and methods

An observational, retrospective, analytical study was conducted that included all newborns with birth weight <1500 g, and in whom surfactant was administered using the INSURE procedure, between 1 March 2011 and 31 March 2014.

Results

A total of 183 cases were managed using the INSURE procedure, finding that 38.8% of the failures were due to the technique, with the main cause being apnoea. Risk factors found were, a lower gestational age, lower birth weight, and a higher grade of respiratory distress prior to using INSURE. Within the neonatal outcomes, a significant association was found with the increased use of mechanical ventilation, days of supplemental oxygen, and bronchopulmonary disease, and mortality in the failure group.

Conclusion

An increased risk of failure in the INSURE procedure was associated with lower gestational age and lower birth weight.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
24
审稿时长
20 weeks
期刊介绍: Perinatología y Reproducción Humana is the official journal of the Instituto Nacional de Perinatología, Mexico. It is aimed at physicians of the area of perinatal and reproductive health (obstetrics and gynecology, maternal and fetal medicine, pediatricians, neonatologists, endocrinologists, infectious disease specialists, and neurologists) and also at health sciences professionals involved in the study of reproduction perinatal and reproductive health (chemists, biologists and neuro-physiologists). It is an electronic biannual journal, that publishes peer-reviewed original articles, in-deep reviews, letters to the editor and special sections related to basic, epidemiological, surgical, and clinical aspects in the area of perinatal and reproductive health, in English or Spanish languages and open access.
期刊最新文献
Uso del paracetamol para el cierre del conducto arterioso en recién nacidos con edad gestacional menor a 35 semanas Utilidad diagnóstica del biomarcador relación plaquetas-linfocitos en rotura prematura de membranas de término y pretérmino INTERNACIONALIZACION DE LA RPRH Y AMPLIACION DE SU AMBITO DE INFLUENCIA ACADEMICA Niveles de estrés en pacientes mexicanas embarazadas seropositivas al VIH Mobbing, amistad y enemistad en instituciones médicas
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1